𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Factors influencing the development of periventricular lucencies in patients with raised intracranial pressure

✍ Scribed by I. F. Moseley; E. W. Radü


Publisher
Springer
Year
1979
Tongue
English
Weight
714 KB
Volume
17
Category
Article
ISSN
0028-3940

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


The effects of dihydroergotamine in pati
✍ P.-O. Grände 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 441 KB

In the first study 6 patients with raised intracranial pressure due to brain oedema following head injury were given dihydroergotamine because of low perfusion pressure. The intracranial pressure fell simultaneously with the increase in arterial pressure. The intracranial pressure fell from 24 +/- 2

Preliminary observations on the use of c
✍ Robert G. Selker; Norman Wolmark; Bernard Fisher; Pearl Moore 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

It has been observed that patients with metastatic brain lesions developed neurologic symptoms when given Corynebacterium parvum. To obtain more information in patients with intracranial mass lesions, intracranial pressures (ICP) were measured or observed in six patients undergoing C. parvum therapy

The influence of head position on the in
✍ B. Urlesberger; W. Müller; E. Ritschl; F. Reiterer 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 279 KB

In order to measure the intracranial pressure (ICP) of 8 newborn with posthemorrhagic hydrocephalus (group A) we used the noninvasive technique via the anterior fontanel (Ladd monitor). The ICP was monitored in two different head positions (30 degrees elevated, horizontal). The median measurements w

The effect of hypertonic sodium chloride
✍ Nicholas Murphy; Georg Auzinger; William Bernel; Julia Wendon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

Acute liver failure (ALF) is a rare condition characterized by the development of encephalopathy in the absence of chronic liver disease. Cerebral edema occurs in up to 80% of patients with Grade IV encephalopathy. In the current prospective randomized controlled clinical trial, we examined the effe